Unknown

Dataset Information

0

Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.


ABSTRACT: Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy. In most cases, specific immunotherapy with birch pollen extracts does not reduce allergic symptoms to the homologue food allergens. We therefore genetically engineered a multi-allergen chimer and tested if mucosal treatment with this construct could represent a novel approach for prevention of birch pollen-related food allergy.BALB/c mice were poly-sensitized with a mixture of Bet v 1, Api g 1 and Dau c 1 followed by a sublingual challenge with carrot, celery and birch pollen extracts. For prevention of allergy sensitization an allergen chimer composed of immunodominant T cell epitopes of Api g 1 and Dau c 1 linked to the whole Bet v 1 allergen, was intranasally applied prior to sensitization.Intranasal pretreatment with the allergen chimer led to significantly decreased antigen-specific IgE-dependent ?-hexosaminidase release, but enhanced allergen-specific IgG2a and IgA antibodies. Accordingly, IL-4 levels in spleen cell cultures and IL-5 levels in restimulated spleen and cervical lymph node cell cultures were markedly reduced, while IFN-? levels were increased. Immunomodulation was associated with increased IL-10, TGF-? and Foxp3 mRNA levels in NALT and Foxp3 in oral mucosal tissues. Treatment with anti-TGF-?, anti-IL10R or anti-CD25 antibodies abrogated the suppression of allergic responses induced by the chimer.Our results indicate that mucosal application of the allergen chimer led to decreased Th2 immune responses against Bet v 1 and its homologue food allergens Api g 1 and Dau c 1 by regulatory and Th1-biased immune responses. These data suggest that mucosal treatment with a multi-allergen vaccine could be a promising treatment strategy to prevent birch pollen-related food allergy.

SUBMITTER: Hoflehner E 

PROVIDER: S-EPMC3387141 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.

Hoflehner Elisabeth E   Hufnagl Karin K   Schabussova Irma I   Jasinska Joanna J   Hoffmann-Sommergruber Karin K   Bohle Barbara B   Maizels Rick M RM   Wiedermann Ursula U  

PloS one 20120629 6


<h4>Background</h4>Among birch pollen allergic patients up to 70% develop allergic reactions to Bet v 1-homologue food allergens such as Api g 1 (celery) or Dau c 1 (carrot), termed as birch pollen-related food allergy. In most cases, specific immunotherapy with birch pollen extracts does not reduce allergic symptoms to the homologue food allergens. We therefore genetically engineered a multi-allergen chimer and tested if mucosal treatment with this construct could represent a novel approach for  ...[more]

Similar Datasets

| S-EPMC4553934 | biostudies-literature
| S-EPMC8073155 | biostudies-literature
| S-EPMC4311984 | biostudies-literature
| S-EPMC5911438 | biostudies-literature
| S-EPMC7460837 | biostudies-literature
| S-EPMC4183528 | biostudies-literature
| S-EPMC7045072 | biostudies-literature
| S-EPMC9268136 | biostudies-literature
| S-EPMC7142267 | biostudies-literature
| S-EPMC7162528 | biostudies-literature